石榴 | 水果界中增强性爱能力之王

没有其他水果或蔬菜像石榴一样那么好地能够促进您变得“威猛”。在提高睾丸激素水平,增加勃起强度和改善心血管健康(这是实现和维持勃起的重要因素)方面,绝对是冠军般的存在。其他任何水果或蔬菜都无法同时满足这三点。
如果您能定期吃石榴,即使是将它榨成果汁(纯粹)后饮用,那就太好了,相信您已经从中获取到了不小的收获。但可能并不是最大的,因为日常我们直接吃石榴或喝石榴汁不能使您发挥其充分的性潜力。
问题就在于,对石榴而言,其大部分成分是一种被称为“punicaligans”的物质。“punicaligans”是一种多酚,后文会直接以【多酚】来描述,也可以被理解为是一种特定的鞣花单宁。例如,鞣花单宁是橡木中的主要单宁,是影响橡木桶贮葡萄酒质量的重要因素之一。这些多酚更多存在于石榴的外皮中,而这常常是被最先丢弃的部分。
因此,要想真正获得石榴中最宝贵的多酚元素对您的身体带来的最大化的增益,那么您必须吃掉更多的干果皮。这种“干皮”早在中医学中被广泛和充分利用其价值,比如入药剂的陈皮(为芸香科植物橘Citrus reticulata Blanco及其栽培变种的干燥成熟果皮。药材分为“陈皮”和“广陈皮”。采摘成熟果实,剥取果皮,晒干或低温干燥)。
1、多酚可升高睾丸激素
当您摄取多酚时,它们会被肠道菌群部分代谢成称为“尿石素(urolithin)”的化合物——一种芳香化酶活性的强大抑制剂。芳香化酶(aromatase)是将睾丸激素转变成雌激素的酶。如果您可以通过尿石素抑制这些芳香化酶的活性,则会自动增加睾丸激素的水平。
这可不是帮助您提升一丁点。一项针对男性和女性的研究发现,多酚为实验组的睾丸激素水平提高了24%。
多酚还可能通过另一种机制来提高睾丸激素水平,这种机制相对较小,但仍然值得关注:与常规组相比,每天摄入多酚的人食欲下降并且进食后可以更好拥有饱腹感,这可以更好使您保持身材。
由于变胖或体重超标会直接导致睾丸激素降低和雌激素水平升高,因此任何有助于减肥的措施都可能具有提高睾丸激素水平的下游作用。
2、当“伟哥”或勃起药物不起作用时,多酚可能会起作用
一氧化氮(NO)是一种化学物质,可使阴茎动脉的平滑肌松弛,从而使得更多的血液流入阴茎,血液流量会是正常情况下的8-10倍。
不幸的是,一氧化氮的水平随着年龄的增长而下降,大约从40岁开始减少,50岁或60岁的男人通常产生的一氧化氮是20岁时的一半,甚至更少。幸运的是,我们可以轻松操纵它,这也是为什么诸如像“伟哥”和“希爱力”(解决勃起功能障碍的药物)可以问世的基础。
在这里,多酚提供了一个高具吸引力的选择:它们可以通过提高神经元型一氧化氮合酶来提高一氧化氮的产量,而万艾可、希爱力等类似的药物则是通过升高内皮型一氧化氮合酶来实现。当然,提高任何一种类型的一氧化氮合酶的活性都可以最终使您收获勃起奖章。
在一项针对61位男性受试者的双盲交叉研究中发现,有47%的人报告说石榴改善了勃起功能,此实验中还只是用的纯粹的石榴,不是精加工后的从石榴中提取的多酚。那么可想而知,如果您直接补充多酚会怎么样?
3、多酚可以改善心血管的健康
勃起的全程正如一个水力装置的运行过程,只要你的血管结实,没有粘连,那么多酚将可以为您提供使阴茎向天空吊起并高耸挺拔所需的压力(稳定力)。
前文我们已经谈到过多酚是如何提高一氧化氮的水平,而一氧化氮本身会打开血管,但是多酚似乎也通过其强大的抗氧化能力整体改善循环系统。多项研究表明,他们可以整体上增强血液流动,甚至可以逆转动脉斑块的生长(根除斑块,使您的身体自动改善血液循环)。
4、石榴:其他与性提升相关的东西
研究发现相比那些不怎么吃石榴的人,经常吃石榴的人会产生更多的精子,并且其精子具有更好的活性和运动能力。同样,这只是纯粹的吃石榴或喝石榴汁,还不是专门摄入石榴中的多酚或专门吃石榴皮,想想一下,如果这样做了,那还得了?
另外,研究发现石榴还可以减少前列腺炎的病发,并且阻止您的前列腺病理性肥大。
所以,在我看来,那些久坐人群们,每天至少吃一个完成的石榴是很有帮助的,而且也很重要的。当然也可以直接吃石榴皮,虽然口感差了点,就像初次吃大蒜一样,适应下应该没什么大不了的。对了,随便说一下,大蒜也是个绝好的食物。
当然,最省事的摄入方法就是直接服用带有多酚的胶囊或“药片”,但目前可能市面上没有公开售卖,至少我没找到。有需要的朋友可以问问专门做运动营养补剂的产商是否有生产。因为这完全可以算作是保健品,正如蛋白粉一样。所以,服用时不要有任何心理负担。
文献参考:
  1. Pooja Sharma, et al. Pomegranate for Prevention and Treatment of Cancer: An Update, Molecules, 24 January 2017. – This review summarizes preclinical and clinical studies highlighting the role of pomegranate in prevention and treatment of skin, breast, prostate, lung, and colon cancers.
  2. Roberto Vicinanza, Yanjun Zhang, Susanne M. Henning, and David Heber, Pomegranate Juice Metabolites, Ellagic Acid and Urolithin A, Synergistically Inhibit Androgen-Independent Prostate Cancer Cell Growth via Distinct Effects on Cell Cycle Control and Apoptosis, Evidence Based Complementary and Alternative Medicine,19 February 2013 – This study describes how ellagitannins (ETs) from pomegranate juice (PJ) are bioactive polyphenols with chemopreventive potential against prostate cancer (PCa).
  3. Lei Wang, et al. Cellular and molecular mechanisms of pomegranate juice-induced anti-metastatic effect on prostate cancer cells, Integr Biol, 2011 May 19 – This study demonstrates how, in addition to causing cell death of hormone-refractory prostate cancer cells, pomegranate also increases cell adhesion and decreases cell migration of the cells that do not die.
  4. Fernando Machado Chaves, et al. Pomegranate Juice and Peel Extracts are Able to Inhibit Proliferation, Migration and Colony Formation of Prostate Cancer Cell Lines and Modulate the Akt/mTOR/S6K Signaling Pathway, Plant Foods Hum Nutr., 2020 March;75(1):54-62. – This study presents evidence that both juice and isolated peel extracts from pomegranate fruit have important anti-cancer effects against prostate cancer cells, modulating the mTOR/S6K signaling pathway.
  5. Cp Forest, et al. Efficacy and safety of pomegranate juice on improvement of erectile dysfunction in male patients with mild to moderate erectile dysfunction: a randomized, placebo-controlled, double-blind, crossover study, Int J Impot Res. Nov-Dec 2007;19(6):564-7 – This randomized-controlled trial examined the efficacy of wonderful variety pomegranate juice versus placebo in improving erections in 53 completed subjects with mild to moderate erectile dysfunction. The crossover design consisted of two 4-week treatment periods separated by a 2-week washout. Of the 42 subjects who demonstrated improvement in GAQ scores after beverage consumption, 25 reported improvement after drinking pomegranate juice. Further, 17 subjects showed preference of one beverage to the other. Subjects were more likely to have improved scores when pomegranate juice was consumed (P=0.058).
  6. Channing J. Paller, et al. A Review of Pomegranate in Prostate Cancer, Prostate Cancer Prostatic Dis. 2017 Sep; 20(3):265-270 – A randomized clinical trial of a polyphenol-rich multi-component food supplement tablet, including 31.25% pomegranate extract, found significant slowing of PSA increase in the food supplement arm vs. placebo in men on active surveillance and those experiencing biochemical recurrence.
  7. David Heber, Chapter 10: Pomegranate Ellagitanins, Herbal Medicine: Biomolecular and Clinical Aspects, 2nd edition. Boca Raton, CRC Press/Taylor & Francis, 2011 – “Since ancient times, pomegranate has been used for medicinal purposes. Extensive research on bioactive substances in the pomegranate extract has shown potential applications in the chemoprevention of common forms of cancer. This work has progressed in cell culture, human studies, and in some clinical research demonstrating the preventive potential of pomegranate. Pomegranates have been shown to contain 124 different phytochemicals, and some of them act in concert to exert antioxidant and anti-inflammatory effects on cancer cells. Ellagitannins are bioactive polyphenols present in pomegranate.”
  8. Matthew Resnick, Complementary and Alternative Medicine (CAM) in Prostate and Bladder Cancer, Primary Care, November 26, 2013 – This article is a summary of the evidence of CAM therapies for prostate and bladder cancer. The author reviewed the evidence and listed the benefits of pomegranate, along with those of green tea, and resveratrol (through grapes and dark-colored berries).
  9. Maryam R Sartippour, Ellagitannin-rich pomegranate extract inhibits angiogenesis in prostate cancer in vitro and in vivo, Int J Oncol. 2008 Feb;32(2): 475-80 – These results demonstrate that an ellagitannin-rich pomegranate extract can inhibit tumor-associated angiogenesis as one of several potential mechanisms for slowing the growth of prostate cancer in chemopreventive applications.
  10. Arrigo F G Cicero, et al. Nutraceutical treatment and prevention of benign prostatic hyperplasia and prostate cancer, Arch Ital Urol Androl. 2019 Oct 2;91(3) – This study explains how medicinal plants, in the form of plant parts or extracts of them, are commonly used for the treatment of prostate diseases such as benign hypertrophy, prostatitis and chronic pelvic pain syndrome. The pharmacological properties searched for the treatment of prostatic diseases are anti-androgenic, anti-estrogenic, antiproliferative, antioxidant and anti-inflammatory.
  11. Navindra P Seeram, et al. Pomegranate ellagitannin-derived metabolites inhibit prostate cancer growth and localize to the mouse prostate gland, J Agric Food Chem. 2007 Sep 19;55(19):7732-7 – The scientists explain how pomegranate juice (PJ) increases prostate specific antigen (PSA) doubling time in prostate cancer (CaP) patients with a rising PSA. Ellagitannins (ETs) are the most abundant polyphenols present in PJ and contribute greatly towards its reported biological properties. On consumption, ETs hydrolyze to release ellagic acid (EA), which is then converted by gut microflora to 3,8-dihydroxy-6H-dibenzo[b, d]pyran-6-one (urolithin A, UA) derivatives. The chemopreventive potential of pomegranate ETs and localization of their bioactive metabolites in mouse prostate tissue suggest that pomegranate may play a role in CaP treatment and chemoprevention.
  12. Nils Kroeger, et al. Pomegranate Extracts in the Management of Men’s Urologic Health: Scientific Rationale and Preclinical and Clinical Data, Evid Based Complement Alternat Med. 2013 Mar 26 – Numerous micronutrients and polyphenols found in soy, green tea, and many fruits and vegetables have been described to impact diseases including erectile dysfunction, benign prostatic hyperplasia, and prostate cancer. However, oftentimes these reports lack both a scientific rationale and supportive evidence base. The efficacy of pomegranate, on the other hand, in the modulation of central biological processes like inflammation, hypoxia, and oxidative stress that are important in the pathogenesis of urological maladies has been robustly demonstrated in preclinical in vitro and in vivo studies. Moreover, clinical trials have further supported its use in the treatment of several diseases, in particular in the management of prostate cancer.
  13. CP Forest, et al. Efficacy and safety of pomegranate juice on improvement of erectile dysfunction in male patients with mild to moderate erectile dysfunction: a randomized, placebo-controlled, double-blind, crossover study, Int J Impot Res. Nov-Dec 2007;19(6):564-7 – This randomized-controlled trial examined the efficacy of wonderful variety pomegranate juice versus placebo in improving erections in 53 completed subjects with mild to moderate erectile dysfunction. The crossover design consisted of two 4-week treatment periods separated by a 2-week washout. Efficacy was assessed using International Index of Erectile Function (IIEF) and Global Assessment Questionnaires (GAQ). Of the 42 subjects who demonstrated improvement in GAQ scores after beverage consumption, 25 reported improvement after drinking pomegranate juice. Further, 17 subjects showed preference of one beverage to the other. Subjects were more likely to have improved scores when pomegranate juice was consumed (P=0.058).
  14. Julie Jeranka,Therapeutic Applications of Pomegranate (Punica granatum L.): A Review, Alternative Medicine Review: A Journal of Clinical Therapeutic, July 2008,13(2):128-44 – In addition to its ancient historical uses, pomegranate is used in several systems of medicine for a variety of ailments. In the past decade, numerous studies on the antioxidant, anticarcinogenic, and anti-inflammatory properties of pomegranate constituents have been published, focusing on treatment and prevention of cancer, cardiovascular disease, diabetes, dental conditions, erectile dysfunction, bacterial infections and antibiotic resistance, and ultraviolet radiation-induced skin damage. Other potential applications include infant brain ischemia, male infertility, Alzheimer’s disease, arthritis, and obesity.
  15. S. Gur, et al. Characterisation of pomegranate juice effects on human corpus cavernosum, Andrologia 2017 Oct;49(8) – This study evaluates the molecular characterisation and confirmation of POM’s action on human corpus cavernosum (HCC) obtained from patients (n = 16) undergoing penile prosthesis implantation. We conclude that POM induced marked relaxation of HCC via: (i) nNOS stimulation, and (ii) downstream relaxation stimulated by nNOS and cGMP and bypassing the NO and PDE5. This action provides a rationale for the therapeutic or preventative use of POM in men with erectile dysfunction who do not respond well to PDE5 inhibitors.
  16. Kazem Azadzoi, et al, Oxidative stress in arteriogenic erectile dysfunction: prophylactic role of antioxidants, J Urol. 2005 Jul;174(1):368-93 – Antioxidant activity of known antioxidant beverages, such as pomegranate juice (PJ), red wine, blueberry juice, cranberry juice, orange juice and green tea, was examined spectrophotometrically. PJ demonstrated the highest free radical scavenging capacity. Antioxidant therapy may be a useful prophylactic tool for preventing smooth muscle dysfunction and fibrosis in ED.
  17. Yuanie Deng, et al. The extract from Punica granatum (pomegranate) peel induces apoptosis and impairs metastasis in prostate cancer cells, Biomed Pharmacother, 2017 Se9;93:976-984 – This study aimed to investigate the effects of pomegranate peel extract (PoPx) on the apoptosis and metastasis of prostate cancer cells and the related mechanism. They found that PoPx showed growth inhibition on prostate cancer cells. Nuclei morphological and flow cytometer (FCM) analysis indicated that PoPx could induce prostate cancer apoptosis. Wound healing assay and transwell migration and invasion assay implied that PoPx has the potential to inhibit migration and invasion, two critical steps in prostate cancer metastasis. Downregulation of MMP2/MMP9 and upregulation of TIMP2 showed accordance with the inhibition of migration and invasion. In summary, the present data showed that PoPx could be a promising drug candidate to treat prostate cancer, showing us a better way to develop novel drugs from natural compounds.
  18. Shahindokht Bassiri-Jahromi, Punica granatum (Pomegranate) activity in health promotion and cancer prevention, Oncol Res. 2018 Jan 30;12(1):345 – The available data suggest that Punica granatum (pomegranate) might be used in the control and potential therapeutic for some disease conditions and benefits human health status. This review summarizes in vitro, in vivo and clinical trial studies highlighting the pomegranate role in prevent and treatment of breast, prostate, lung, colon, skin and hepatocellular cell cancers.
  19. Sigrun Chrubasik-Hausman, et al. Pomegranate juice and prostate cancer: importance of the characterisation of the active principle, Phytoter Res. 2014 Nov;28(11):1676-8 – Two exploratory clinical studies investigating proprietary pomegranate products showed a trend of effectiveness in increasing prostate-specific antigen doubling time in patients with prostate cancer. A recent clinical study did not support these results. We therefore analysed a lot of the marketed pomegranate blend for co-active pomegranate compounds. The results show that the co-active compounds in the daily dose of the pomegranate blend were far below those previously tested and that the photometric assessment is not reliable for the standardisation of study medications. Not pomegranate but the low amount of co-active compounds in the proprietary pomegranate blend was responsible for its clinical ineffectiveness.
  20. Lei Wang, et al. Pomegranate and Its Components as Alternative Treatment for Prostate Cancer, Int J Mol Sci. 2014 Sep; 15 (9):14949-14966 – Recent research has shown that pomegranate juice (PJ) and/or pomegranate extracts (PE) significantly inhibit the growth of prostate cancer cells in culture. In preclinical murine models, PJ and/or PE inhibit growth and angiogenesis of prostate tumors. More recently, it has been shown that three components of PJ, luteolin, ellagic acid and punicic acid together, have similar inhibitory effects on prostate cancer growth, angiogenesis and metastasis. Results from clinical trials are also promising. PJ and/or PE significantly prolonged the prostate specific antigen (PSA) doubling time in patients with prostate cancer.
  21. Zahra Amri, et al. Growth Inhibitory and Pro-Apoptotic Effects of Ornamental Pomegranate Extracts in Du145 Human Prostate Cancer Cells, Nutrition and Cancer, Volume 72, 2020, issue 6 – This study was aimed to investigate the influence of dwarf pomegranate extracts (peel, juice, and seeds oil) on the proliferation and apoptosis of human prostate androgen-independent cell line DU145. The three tested extracts exhibited a dose-response cytotoxic effect and antiproliferative action on DU145 cell line and induce morphological changes. The three extracts could also induce prostate cancer cell apoptosis by an increase of DNA fragmentation, PARP cleavage, and inhibition of the COX-2 expression. The strongest pro-apoptotic effect was shown after peel treatment.
(0)

相关推荐